FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a topical pharmaceutical composition in the form of an opaque emulsion gel. The composition contains 1.2-4 wt % of diclofenac diethylammonium salt, saturated or unsaturated C10-C18fatty alcohol, at least 40 wt % of water, C2-C4alkanol, glycol solvent, gelling agent, liquid lipid forming an oil phase of the emulsion gel, non-ionic surfactant and agent with the primary properties to reduce pH of the prepared composition to 6-9.
EFFECT: compositions under the invention are characterised by high skin permeability, extremely low systemic absorption, absence of human skin irritation after application, high chemical and physical stability, complete solubility of the active component and considerable relief of pain intensity.
8 cl, 4 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
DICLOFENAC SODIUM COMPOSITION FOR TOPICAL APPLICATION | 2015 |
|
RU2702898C2 |
COMPOSITIONS FOR PERCUTANEOUS ADMINISTRATION | 2009 |
|
RU2497506C2 |
ANTI-INFLAMMATORY FORMULATION AND PROCESS FOR PREPARING THE SAME | 1989 |
|
RU2008002C1 |
COMPOSITIONS AND USE THEREOF FOR TREATING OR PREVENTING ROSACEA | 2017 |
|
RU2738932C2 |
DELIVERY SYSTEMS FOR LOCAL APPLICATION FOR ACTIVE SUBSTANCES | 2018 |
|
RU2777644C2 |
COMBINATION OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS AND NON-STEROID ANTI-INFLAMMATORY DRUG FOR TREATING OR PREVENTING INFLAMMATORY SKIN INJURY | 2010 |
|
RU2532388C2 |
PHARMACEUTICAL COMPOSITION FOR TOPIC APPLICATION | 2008 |
|
RU2468794C2 |
TOPICAL AGENT FOR TREATING JOINT AND SOFT-TISSUE DISORDERS | 2013 |
|
RU2574008C2 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTI-INFLAMMATORY AND ANALGESIC EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2309738C1 |
PHARMACEUTICAL COMPOSITIONS | 2010 |
|
RU2589699C2 |
Authors
Dates
2013-11-10—Published
2008-10-27—Filed